13 May 2024

Asante, KP, Oduro, A, Welega, P, Ansong, D, Odei-Lartey, E, Gyan, T, Gyaase, S, Sarfo, A, Samuels, A, Westercamp, N, Akech, S, Kwambai, T, Khazenzi, C, Milligan, P, Snell, P, Moore, K, Fogelson, A, Schellenberg, D, Hamel, M, Okine, R, Mathanga, D, Mwapasa, V, Kapito, A, Mvalo, T, Msuku, H, Stanley, C, Njuguna, P, Kariuki, S, Otieno, L, Chimala, A, Afari, EA, Bejon, P, Maleta, K, Agbenyega, T, Snow, RWv, Zulu, M, Chinkhumba, J, Chinkumba, J, Abubakari, SW, Akumani, A, Adu-Gyasi, D, Agbokey, F, Amenga-Etego, S, Buabeng, P, Awini, E, Sylverken, J, Kampim, A, Koram, KA, Hodgson, A, Binka, FN, Tweneboah, PO, Ondiegi, B, Seda, B, Akach, D, Orwa, G, Nyang’au, I, Odunga, O, Gumba, F, Copeland, N, Mumo, E, Musa, M, English, M, Haji, A, Njoroge, J, Msuku, H, Samuel, V, Mariko, HT, Juliano, J, Msumba, L, Mungwira, RG, Zimba, BE, Desai, M, Furrer, E, Aponte, J, Alonso, P, Sillah, JS and Kalu, AA (2024). Replication Data for: Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi. [Data Collection]. Harvard Dataverse. https://doi.org/10.7910/DVN/VOZU4T